Margaret Tooth Sells 491 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 491 shares of the stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $31.84, for a total value of $15,633.44. Following the completion of the transaction, the chief executive officer directly owned 186,952 shares in the company, valued at $5,952,551.68. This trade represents a 0.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Margaret Tooth also recently made the following trade(s):

• On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The shares were sold at an average price of $29.05, for a total value of $28,410.90.

Trupanion Stock Performance

Shares of NASDAQ:TRUP opened at $29.65 on Friday. The business has a 50-day moving average of $26.88 and a two-hundred day moving average of $25.97. The firm has a market capitalization of $1.30 billion, a PE ratio of 55.94, a P/E/G ratio of 2.04 and a beta of 1.39. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. Trupanion, Inc. has a 12 month low of $21.16 and a 12 month high of $46.98.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The business had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. During the same period in the previous year, the company posted $0.22 EPS. The company’s revenue was up 11.1% compared to the same quarter last year. As a group, research analysts forecast that Trupanion, Inc. will post 0.63 earnings per share for the current year.

Hedge Funds Weigh In On Trupanion

Several institutional investors and hedge funds have recently made changes to their positions in the business. Thrivent Financial for Lutherans raised its holdings in Trupanion by 1.1% in the second quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock valued at $1,376,000 after acquiring an additional 282 shares in the last quarter. EP Wealth Advisors LLC grew its holdings in Trupanion by 2.9% during the 2nd quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock worth $571,000 after acquiring an additional 292 shares in the last quarter. Illinois Municipal Retirement Fund increased its position in shares of Trupanion by 2.3% in the 1st quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider’s stock worth $456,000 after purchasing an additional 406 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Trupanion by 2.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 33,657 shares of the financial services provider’s stock valued at $1,258,000 after purchasing an additional 725 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Trupanion by 3.8% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock worth $1,126,000 after purchasing an additional 737 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on TRUP. Piper Sandler downgraded shares of Trupanion from an “overweight” rating to a “neutral” rating and cut their target price for the company from $45.00 to $32.00 in a research note on Wednesday. Stifel Nicolaus raised their price objective on Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research report on Thursday, August 20th. Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday. Weiss Ratings upgraded shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday. Finally, Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research note on Wednesday, July 15th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Trupanion currently has an average rating of “Hold” and an average price target of $39.20.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.